Health workers at a testing camp in delhi. Photo: Manas Ranjan Bhui
Rohtak, November 18
India is going to be amongst the pioneering nations of the world with the development of its indigenous Covid vaccine Covaxin in the near future. Indian Covid-19 vaccine is unique as it has shown minimum side-effects.
This was stated by Dr OP Kalra, Vice Chancellor of Pt Bhagwat Dayal Sharma University of Health Sciences, Rohtak, while addressing a news conference here today.
Professor Kalra disclosed that the third phase of the clinical human trials of Covaxin would begin at the Rohtak PGIMS on November 19. — TNS
Join Whatsapp Channel of The Tribune for latest updates.
Most Read In 24 Hours
Don't Miss
View All
Top News
PM Modi targets Rahul Gandhi, says after Amethi, Congress' ‘sahabzade’ will lose Wayanad seat also
Modi says some INDIA bloc leaders left Lok Sabha and moved t...
US sanctions Chinese suppliers for providing critical components of Pakistan’s ballistic missile programme
As a result of the action, all property and interests in pro...
Iraq's popular mobilization forces post hit in air strike, sources say
US official said there had been no US military activity in I...
Karnataka minister apologises to Neha's parents even as mother of killer says 'my son should be punished'
Reacting to the incident Parameshwara had stated that Neha a...
Indian student's death in US possibly linked to 'Blue Whale Challenge': Report
The 20-year-old, who will remain unnamed here in deference t...
